Patents for A61P 23 - Anaesthetics (4,141)
05/1997
05/27/1997US5633000 Subcutaneous implant
05/18/1997CA2163163A1 Low-irritation anesthetic and antiseptic mouth rinse
05/14/1997CN1149464A New matrix magnetic therapeutic anesthesia analgesic paste
05/13/1997US5629326 Analgesics and antipsychotics, indazole, benzisoxazole, and benzisothiazole derivatives
05/09/1997WO1997016440A1 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
05/02/1997EP0769949A1 Hydromorphone therapy
05/01/1997WO1997015548A1 New [(3-alkoxy-phenoxy)-ethyl]-dialkylamine derivatives and their use as local anaesthetics
04/1997
04/29/1997US5624927 N-[4-(heteroaryl)-1-piperazinyl)alkyl]-1,2,3,4-tetrahydroisoquinolines and n-[4(heteroaryl)-1-piperazinyl)alkyl]-1,2,3,4-tetrahydroisoquinolines, related compounds and their therapeutic utility
04/09/1997EP0766538A1 Subcutaneous implant
03/1997
03/25/1997US5614543 1-(aryloxyalkyl)-3- (heteroaryl) pyrrolidines and related compounds useful as antipsychotics and analgesics
03/19/1997EP0763038A1 The preparation of nalbuphine having low levels of beta-epimer
03/18/1997US5612343 N-[(4-heteroaryl-1-piperazinyl)alkyl]-2,3-naphthalimides and related compounds and their therapeutic utility
03/06/1997WO1997007793A1 Formulations of haloalkylamines and local anaesthetics and methods for the treatment of reflex sympathetic dystrophy (rsd)
03/06/1997WO1997007750A1 Administration of ketamine to manage pain and to reduce drug dependency
03/06/1997CA2230648A1 Formulations of haloalkylamines and local anaesthetics and methods for the treatment of reflex sympathetic dystrophy (rsd)
03/04/1997US5607945 Use as antipsychotics, analgesics and depot pharmaceuticals
02/1997
02/13/1997WO1997004728A1 Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals
02/13/1997WO1996032109A3 Levobupivacaine and its use as an anaesthetic in pregnant women
02/11/1997US5601839 Triacetin as a penetration enhancer for transdermal delivery of a basic drug
02/05/1997CN1142226A Novel heterocyclic compounds
02/04/1997US5599821 4-heteroaryl-1-piperidinealkylamines and derivatives thereof and their therapeutic utility
01/1997
01/28/1997US5597842 3-heteroaryl-1-pyrrolidinealkanols and derivatives thereof and their therapeutic utility
01/21/1997US5595989 Antiinflammatory agents and antidiabetic agents
01/15/1997CN1140448A New compounds with analgesic and local anaesthetic effect
01/14/1997US5593995 Treatment of psychoses and psychological disorders; analgesics
01/14/1997US5593983 Preparation by reacting substituted /thio/morpholine or salt and 2,3-epoxyandrostane or 2,3-epoxy-19-nor-androstane; use to induce anesthesia
01/08/1997EP0751766A1 Nasal and ocular administration of ketamine to manage pain and for detoxification
01/07/1997US5591745 (4-heteroaryl)-1-[(2,3-dihydro-1H-isoindol-2-yl)alkyl] piperidines and related compounds and their therapeutic utility
01/07/1997US5591452 Controlled release formulation
01/02/1997EP0750909A1 The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence
12/1996
12/31/1996US5589495 2-[(3-heteroaryl-1-pyrrolidinyl)alkyl]-1,3- indandiones and related compounds and their therapeutic utility
12/31/1996US5589494 2-[(3-heteroaryl-1-pyrrolidinyl)alkyl]-1,3-dioxanes and related compounds and their therapeutic utility
12/31/1996US5589488 Antipsychotic agents, analgesics
12/31/1996US5589192 Gel pharmaceutical formulation for local anesthesia
12/31/1996US5589156 Prilocaine and hydrofluourocarbon aerosol preparations
12/27/1996CA2349017A1 Formulations and methods for providing prolonged local anesthesia
12/24/1996US5587376 Antiischemic agents, decongestants
12/17/1996US5585385 Heterocyclic compounds, their production and use as tachykinin reactor antagonists
12/17/1996CA2062137C Method for anesthesia
12/10/1996US5583145 Psychological disorders
12/05/1996WO1996038559A1 Chemokine n-terminal deletion mutations
12/03/1996US5580901 Percutaneous anesthetics
12/03/1996US5580892 Antidiarrhetic, antispastic, antiepileptic agents; diuretics
12/03/1996US5580891 Antipsychotic agents, analgesics
12/03/1996US5580890 Psychological disorders
12/03/1996US5580887 1- (arylthioalkyl , arylaminoalkyl or arylmethylenealkyl) -4- (heteroaryl) piperidines and related compounds useful as anti-psychotics and analgesics
12/03/1996US5580886 Cis-2-[(4-heteroaryl-1-piperidinyl)alkyl]hexahydro-1H-isoindole-1,3(2H)-diones and related compounds and their therapeutic utility
12/03/1996US5580879 N-[(4-heteroaryl-1-pyrrolidinyl)alkyl]-1H-benz[DE]isoquinoline-1;3(2H)-diones and related compounds and their therapeutic utility
12/03/1996US5580875 Antipsychotic and analgesic agents
11/1996
11/28/1996WO1996037500A1 Novel quinoxaline dione derivatives, their production and their use in medicaments
11/28/1996DE19519979A1 Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln New quinoxalinedione derivatives, their preparation and use in medicaments
11/28/1996CA2221695A1 New quinoxalinedione derivatives, their production and use in pharmaceutical agents
11/27/1996EP0743940A1 New compounds with analgesic and local anaesthetic effect
11/26/1996US5578624 Heteroarylpyrrolidines and their use as antipsychotics and analgesics
11/26/1996US5578605 N-[(4-heteroaryl)-1-piperidinyl)alkyl]-1,2,3,4-tetrahydroquinolines and related compounds and their therapeutic utility
11/20/1996CN1136275A Heteroarylpiperidines, pyrrolidines and piprazines and their use as antipsychotics and analgetics
11/13/1996EP0741709A1 Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
11/12/1996US5574032 Antipsychotic agents, analgesics
11/05/1996US5571828 N-[(3-heteroaryl-1-pyrrolidinyl)alkyl]-2,3-napthalimides and related compounds and their therapeutic utility
11/05/1996US5571814 N-[(4-heteroaryl-1-pyrrolidinyl)alkyl]phthalimides and related compounds and their therapeutic utility
11/05/1996US5571803 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
10/1996
10/31/1996WO1996033678A1 Triacetin as a transdermal penetration enhancer
10/29/1996US5569653 N-[(4-(heteroaryl)-1-pyrrolidinyl)alkyl]-10,11-dihydro-5H-dibenz[B,F]azepines and related compounds and their therapeutic utility
10/23/1996EP0738262A1 Novel heterocyclic compounds
10/17/1996WO1996032109A2 Levobupivacaine and its use as an anaesthetic in pregnant women
10/09/1996EP0735888A1 Purine compositions and methods for administration
10/09/1996EP0735873A1 Use of pyridone derivatives as anesthetic drugs
10/03/1996WO1996030339A1 Pyrrolidinyl hydroxamic acid compounds and their production process
10/01/1996US5561132 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
09/1996
09/26/1996WO1996029066A1 Prilocaine and hydrofluorocarbon aerosol preparations
09/26/1996WO1996029064A1 Oil in water emulsions containing propofol and edetate
09/26/1996WO1996029052A1 Aerosolized general anesthetic agents
09/26/1996CA2215696A1 Aerosolized general anesthetic agents
09/24/1996US5559126 Analgesics, antipsychotic agents
09/24/1996US5559117 N-[(4-heteroaryl-1-piperazinyl) alkyl]-2-Benoxazolinines and related compounds and their therapeutic utility
09/24/1996US5559116 Analgesics, antipsychotic agents
09/19/1996DE19509828A1 Oil-in-water emulsion for parenteral admin. contg. EDTA as antimicrobial agent
09/17/1996US5556858 Cis-2-[(4-heteroaryl-1-piperazinyl)alkyl] hexahydro-1H-isoindole-1,3 (2H)-diones and related compounds and their therapeutic utility
09/11/1996EP0730452A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
09/10/1996US5554614 Treatment of psychological disorders, psychoses; analgesics
09/04/1996EP0729751A1 Controlled release formulation containing tramadol
09/03/1996US5552414 Antipsychotic agents and analgesics
09/03/1996US5552403 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
08/1996
08/27/1996US5550130 1-[(1,4-benzodioxanyl)alkyl]-4-(heteroaryl)piperidines and related compounds and their therapeutic utility
08/27/1996CA1338556C 4-substituted imidazole derivatives useful in perioperative care
08/07/1996EP0724439A1 Use of 2-(2-alkylphenylamino)-oxazolines, -thiazolines and -imidazolines as alpha 2 adrenergic agents
08/06/1996US5543434 Nasal administration of ketamine to manage pain
07/1996
07/31/1996EP0723447A1 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
07/10/1996CN1126435A Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
06/1996
06/25/1996US5529787 Hydromorphone therapy
05/1996
05/30/1996WO1996016076A1 Androstane and pregnane series for allosteric modulation of gaba receptor
05/30/1996CA2205919A1 Androstane and pregnane series for allosteric modulation of gaba receptor
04/1996
04/17/1996EP0706395A1 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
04/03/1996EP0703919A1 Phosphosuccinic acid derivatives and their use as medicaments
03/1996
03/21/1996WO1996008241A1 Anaesthetic analgesic gas mixtures containing enflurane or isoflurane in combination with sevoflurane or desflurane
03/21/1996CA2199048A1 Anaesthetic analgesic gas mixtures containing enflurane or isoflurane in combination with sevoflurane or desflurane
03/06/1996EP0699436A1 Controlled release formulation
03/05/1996US5496537 General anesthetics for nasal delivery using propofol with propellants
03/05/1996CA2010022C Anesthetic oral compositions
02/1996
02/14/1996EP0696197A1 Analgesic anaesthetic compositions
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42